Browsing by Author "Mühlebach, M. D."

K-REx Repository

Browsing by Author "Mühlebach, M. D."

Sort by: Order: Results:

  • Weiss, K.; Salzig, D.; Röder, Y.; Gerstenberger, J.; Mühlebach, M. D.; Cichutek, K.; Pörtner, R.; Czermak, Peter (2013)
    Recombinant measles viruses are currently tested in clinical trials as oncolytic agent to be applied in cancer therapy. Contrary to their use as vaccine where 10³ infectious virus particles per dose are needed, for cancer ...
  • Weiss, K.; Salzig, D.; Mühlebach, M. D.; Cichutek, K.; Pörtner, R.; Czermak, Peter (2012)
    Attenuated measles virus has revealed selective tumor cell killing and is currently tested in clinical trials for the therapy of cancer patients. The amount of infectious particles per dose needed for oncolytic therapy can ...